Reconstructive Surgery
16
3
3
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
1 terminated out of 16 trials
88.9%
+2.4% vs benchmark
6%
1 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (16)
App-Assisted Swallowing Program After Oral Cancer Surgery
Postoperative Management of Patients Undergoing Head and Neck Microvascular Free Flap Reconstructive Surgery: is Admission to an Intensive Care Unit Necessary?
Retrospective Analysis of Surgical Outcomes in Patients Treated for Gunshot-Related Bone Defects at Mekelle University Hospital
Lateral Arm Free Flap: a Useful Flap in the Maxillo-facial Surgeon's Therapeutic Armory, Case Series
3D Telemedicine: A Clinician Feedback Study
STARS-R Registry: Retrospective Analysis of Poly-4-hydroxybutyrate (P4HB) Scaffold Use
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
AFT: Introduction of a Full Breast Reconstructive Method
Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
Comparison of Choosing Free ALT or Free PMT for Reconstruction With Head and Neck Cancer
Fluorescence Angiography: Planning and Monitoring of Perforator Flaps
PRF and Connective Tissue Graft in Interdental Papilla Reconstruction
Enoxaparin Metabolism in Reconstructive Surgery Patients
The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial
Evaluation of NEVELIA® in Terms of Safety and Efficacy for Third-degree Burns Treatment or Reconstructive Surgery
Microcirculation in Perforator Flaps. Enhancing Tissue Survival